Profile
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the way 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime are treated, given that the current standard of care is an over 84-year-old technology. Hyivy is creating the first data-driven pelvic rehabilitation system for the over 60 million women with hypertonic, painful pelvic floor conditions. Hyivy is currently raising a seed round of $2 million to have a FDA and Health Canada cleared, clinically validated and commercial ready product for 2023.
Event details
Date: September 21 - 23, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
10 in total
-
Able Innovations is solving the repetitive and labour-intensive task of patient transfers by developing robotic medical… -
Cohesys is a Toronto-based medical device manufacturer that has developed BoneTape, a resorbable tape for bone fracture… -
EmergConnect aims to change the way patients think about same-day care through a digital platform for patient self-… -
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure… -
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is… -
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary… -
Quthero is an early-stage life sciences startup developing applications for its platform technology--a unique, patented… -
Translucent Computing’s Emrchiver enables value-based care for better patient outcomes without vendor lock-in.…